F. Figoli

679 total citations
29 papers, 554 citations indexed

About

F. Figoli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, F. Figoli has authored 29 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in F. Figoli's work include Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Colorectal Cancer Treatments and Studies (5 papers). F. Figoli is often cited by papers focused on Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Colorectal Cancer Treatments and Studies (5 papers). F. Figoli collaborates with scholars based in Italy, United States and Japan. F. Figoli's co-authors include M. Clerici, Lucio Crinò, Maurizio Tonato, Vincenzo Adamo, Filippo de Marinis, M. Marangolo, Luigi Dogliotti, Pasquale Incoronato, Giorgio V. Scagliotti and Giorgio Cruciani and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

F. Figoli

29 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Figoli Italy 10 363 336 143 62 62 29 554
Ignazio Carreca Italy 12 372 1.0× 177 0.5× 178 1.2× 88 1.4× 51 0.8× 35 722
M.C. Pennucci Italy 9 287 0.8× 355 1.1× 93 0.7× 25 0.4× 41 0.7× 17 504
M. Sassi Italy 7 361 1.0× 345 1.0× 65 0.5× 62 1.0× 37 0.6× 9 529
W.K. Evans Canada 10 253 0.7× 200 0.6× 39 0.3× 62 1.0× 99 1.6× 31 538
M. Patrick Stagg United States 10 284 0.8× 143 0.4× 89 0.6× 127 2.0× 34 0.5× 21 523
J.J. Grau Spain 9 312 0.9× 216 0.6× 112 0.8× 152 2.5× 42 0.7× 14 543
Esteban Salgado Spain 13 469 1.3× 232 0.7× 117 0.8× 105 1.7× 48 0.8× 22 596
E. Villafranca Spain 11 341 0.9× 171 0.5× 94 0.7× 198 3.2× 27 0.4× 42 589
Yeun Mi Yim United States 11 270 0.7× 139 0.4× 68 0.5× 36 0.6× 29 0.5× 27 427
P. P. A. Razenberg Netherlands 5 210 0.6× 270 0.8× 41 0.3× 54 0.9× 21 0.3× 7 463

Countries citing papers authored by F. Figoli

Since Specialization
Citations

This map shows the geographic impact of F. Figoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Figoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Figoli more than expected).

Fields of papers citing papers by F. Figoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Figoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Figoli. The network helps show where F. Figoli may publish in the future.

Co-authorship network of co-authors of F. Figoli

This figure shows the co-authorship network connecting the top 25 collaborators of F. Figoli. A scholar is included among the top collaborators of F. Figoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Figoli. F. Figoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casotto, Veronica, Eliana Ferroni, Nicola Gennaro, et al.. (2017). End-of-Life Place of Care, Health Care Settings, and Health Care Transitions Among Cancer Patients: Impact of an Integrated Cancer Palliative Care Plan. Journal of Pain and Symptom Management. 54(2). 167–175. 12 indexed citations
2.
Pellizzari, Michele, David S.C. Hui, Samantha Serpentini, et al.. (2016). Impact of intensity and timing of integrated home palliative cancer care on end-of-life hospitalization in Northern Italy. Supportive Care in Cancer. 25(4). 1201–1207. 20 indexed citations
3.
Ferroni, Eliana, Francesco Avossa, F. Figoli, et al.. (2016). Intensity of Integrated Primary and Specialist Home-Based Palliative Care for Chronic Diseases in Northeast Italy and Its Impact on End-of-Life Hospital Access. Journal of Palliative Medicine. 19(12). 1260–1266. 14 indexed citations
4.
Costanzo, Francesco Di, Silvia Gasperoni, P Malacarne, et al.. (1998). High-Dose Folinic Acid and 5-Fluorouracil Alone or Combined With Hydroxyurea in Advanced Colorectal Cancer. American Journal of Clinical Oncology. 21(4). 369–375. 9 indexed citations
5.
Crinò, Lucio, Giorgio V. Scagliotti, M. Marangolo, et al.. (1997). Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.. Journal of Clinical Oncology. 15(1). 297–303. 268 indexed citations
6.
7.
8.
Crinò, Lucio, M. Marangolo, F. Figoli, et al.. (1995). 1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study. European Journal of Cancer. 31. S222–S222. 12 indexed citations
9.
10.
Danieli, Daniela, et al.. (1992). [Bilateral nodular pulmonary histoplasmosis: cytohistological correlation].. PubMed. 83(1084). 197–200. 6 indexed citations
11.
Figoli, F., Enzo Galligioni, Diana Crivellari, et al.. (1991). Evaluation of Two Consecutive Regimens in Advanced Gastric Cancer. Cancer Investigation. 9(3). 257–262. 6 indexed citations
12.
Costanzo, Francesco Di, P Malacarne, S. Zironi, et al.. (1991). Preliminary report of high dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: A randomized trial of the italian oncology group for clinical research. Journal of Surgical Oncology. 48(S2). 137–140. 1 indexed citations
13.
Montaldo, P. G., F. Figoli, Roberto Sorio, et al.. (1990). Pharmacokinetics of Intrapleural versus Intravenous Etoposide (VP 16) and Teniposide (VM 26) in Patients with Malignant Pleural Effusion. Oncology. 47(1). 55–61. 6 indexed citations
14.
Figoli, F., Andrea Veronesi, Marco Trovò, et al.. (1989). Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 24(6). 381–5. 6 indexed citations
15.
Figoli, F., et al.. (1989). Leucovorin calcium enhancement of mucositis after continuous infusion fluorouracil and short infusion cisplatin.. Journal of Clinical Oncology. 7(5). 680–681. 3 indexed citations
16.
Figoli, F., Andrea Veronesi, Andrea Ardizzoni, et al.. (1988). Cisplatin and Etoposide as Second-Line Chemotherapy in Patients with Small Cell Lung Cancer. Cancer Investigation. 6(1). 1–5. 24 indexed citations
17.
Galligioni, Enzo, Luciano Canobbio, F. Figoli, et al.. (1987). Cisplatin and 5-fluorouracil combination chemotherapy in advanced and/or metastatic colorectal carcinoma: A phase II study. European Journal of Cancer and Clinical Oncology. 23(6). 657–661. 7 indexed citations
18.
Figoli, F., Umberto Tirelli, Roberto Sorio, et al.. (1987). Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion. Cancer Chemotherapy and Pharmacology. 20(3). 239–242. 14 indexed citations
19.
Tirelli, Umberto, et al.. (1987). Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 20(1). 67–70. 8 indexed citations
20.
Lestuzzi, Chiara, Gian Luigi Nicolosi, Daniela Pavan, et al.. (1985). Neoplastic infiltration of the myocardium: in vivo diagnosis and follow-up by two-dimensional echocardiography. 4(1). 55–59. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignazio Carreca Breakdown of academic impact, for papers by M.C. Pennucci Breakdown of academic impact, for papers by M. Sassi Breakdown of academic impact, for papers by W.K. Evans Breakdown of academic impact, for papers by M. Patrick Stagg Breakdown of academic impact, for papers by J.J. Grau Breakdown of academic impact, for papers by Esteban Salgado Breakdown of academic impact, for papers by E. Villafranca Breakdown of academic impact, for papers by Yeun Mi Yim Breakdown of academic impact, for papers by P. P. A. Razenberg
Rankless by CCL
2026